Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study☆☆☆★
Sign Up to like & getrecommendations! Published in 2019 at "Contraception"
DOI: 10.1016/j.contraception.2018.11.001
Abstract: Objectives The primary objective of this study was to compare the 12-month continuation rate for women who self-injected subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) with that for women receiving intramuscular depot-medroxyprogesterone acetate (DMPA-IM) from a provider. This… read more here.
Keywords: provider; continuation; study; contraception ... See more keywords
Self-injected contraceptives: does the investment reflect women’s preferences?
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Global Health"
DOI: 10.1136/bmjgh-2022-008862
Abstract: Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected. Substantial research and advocacy investments have been made to… read more here.
Keywords: self injected; self injection; research; dmpa ... See more keywords